Hi @Mason14 well done
In response to your challenge, I've tried and failed miserably to think of a single reason why, if our PoC trials show efficacy (and reconfirm safety), RAC would be worth less to a well-informed buyer than any of Juno, Loxo or Forty Seven. Of course, they would pay as little as they could get away with.
Love your work.
Speculative M&A Transaction Analysis, page-5
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.030(2.46%) |
Mkt cap ! $201.9M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.19 | $28.31K | 23.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 813 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 450 | 1 |
View Market Depth
| Last trade - 11.51am 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.20 |
Change
-0.030 ( 0.84 %) |
||||
| Open | High | Low | Volume | ||
| $1.22 | $1.25 | $1.20 | 6482 | ||
| Last updated 11.19am 08/05/2024 ? | |||||
| RAC (ASX) Chart |